Systemic Lupus
We are currently enrolling participants for clinical trials focused on new treatments for Systemic Lupus. These studies aim to manage symptoms, reduce disease activity, and…
BLOG
mRNA Vac Booster COVID
Our clinic is now recruiting for a clinical trial studying an mRNA COVID-19 booster vaccine. Eligible participants may receive an investigational booster and study-related care…
GLOW- Influenza Vac 50 +Y
The GLOW Influenza Vaccine clinical trial is assessing the safety, tolerability, and immune response of an investigational flu vaccine in adults age 50 and older.…
Celiac Disease
Our Celiac Disease clinical trials investigate emerging therapies targeting immune response regulation and intestinal recovery. Qualified individuals are invited to participate.
Myasthenia Gravis
Our Myasthenia Gravis clinical trials investigate emerging therapies designed to improve neuromuscular transmission and reduce disease burden. Qualified individuals are encouraged to participate.
Lupus
We are currently enrolling participants for clinical trials focused on new treatments for Lupus. These studies aim to reduce symptoms, manage inflammation, and improve overall…
Chronic Kidney Disease
Our Chronic Kidney Disease clinical trials investigate emerging therapies aimed at preserving kidney function, reducing complications, and improving patient outcomes. We are actively seeking qualified…
Vulvovaginal Candidiasis
We are currently enrolling participants for clinical trials evaluating new treatments for Vulvovaginal Candidiasis. These studies aim to relieve symptoms, prevent recurrence, and improve overall…
Type 2 diabetes/GLP 1 Device
We are offering access to clinical trials testing a new GLP-1 device for Type 2 Diabetes. This research may provide a more effective and user-friendly…
Crohns Disease
Our clinic is offering access to advanced clinical trials for Crohn’s Disease. These research studies give patients the opportunity to explore promising new therapies under…
Ulcerative Collitis
We are currently enrolling participants for clinical trials focused on new treatments for Ulcerative Colitis. These studies aim to improve symptoms, enhance quality of life,…
EmVenio Research and Health Wizz partner to reach patients across the US
U.S.-based researcher and Health Wizz partner to provide clinical research as a care option
DURHAM, N.C., May 14, 2024 /PRNewswire/ — EmVenio Research and Health Wizz are thrilled to announce their partnership to enhance site management and participant engagement in clinical trials. This collaboration combines EmVenio’s expertise in Localization and Hybrid Clinical Trials with Health Wizz’s innovative platform, which integrates with Electronic Health Records (EHRs) and features a patient engagement app. This partnership aims to streamline the clinical trial process, improving patient enrollment and engagement, and offering healthcare providers a comprehensive, turn-key solution for conducting efficient and patient-centric clinical research.
Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
Partnership to provide clinical research to patients across the country DURHAM, N.C., April XX, 2024 – Community research provider EmVenio Research and Prime Healthcare, an…
Clinical Trial Recruitment in Primay Care Clinics
Insufficient recruitment has been found to be the leading cause of early termination of clinical trials. Improving support for primary care provider (PCP) referral of…
Physician Engagement in Clinical Trial Recruitment
Clinical trials are moving toward a decentralized approach post-COVID-19. The opinion in the industry is that it is inevitable that many components of clinical trials,…